drugset / Trial / NCT00548561

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

NCT00548561

Phase 2/3 Completed 23 enrolled Valerio Therapeutics
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to avoid surgical intervention following extravasation of anthracycline chemotherapy out of a vessel into the surrounding tissues.

Timeline

Start
2001-06
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexrazoxane Small molecule 1000 mg/m2 Intravenous